Navigation Links
LX4211 Achieves Positive Results in Type 2 Diabetes Patients with Renal Impairment
Date:10/1/2013

hief medical officer.  "The post-prandial glucose reductions and GLP-1 elevations observed in this study population support the rationale for demonstrating effective HbA1c reduction in a larger, longer-term Phase 3 trial, and provide further support for the clinical differentiation of LX4211 as a first-in-class dual SGLT1 and SGLT2 inhibitor." 

In this multicenter study, 30 patients with poorly controlled type 2 diabetes and moderate to severe renal impairment were randomized to either placebo or a 400 mg dose of investigational drug LX4211 taken orally once per day before breakfast. Patients' post-prandial glucose was measured after a standardized meal both at baseline before treatment and after one week of therapy. In addition to achieving the primary efficacy objective of post-prandial glucose reduction, there were no serious adverse events observed in the study and no discontinuations of LX4211 due to adverse events. Lexicon plans to present full results of the study at scientific congresses in 2014.

About Lexicon

Lexicon is a biopharmaceutical company focused on discovering breakthrough treatments for human disease.  Lexicon currently has multiple programs in clinical development for diabetes, irritable bowel syndrome, carcinoid syndrome and other indications, all of which were discovered by Lexicon's research team.  Lexicon has used its proprietary gene knockout technology to identify more than 100 promising drug targets.  Lexicon has focused drug discovery efforts on these biologically-validated targets to create its extensive pipeline of clinical and preclinical programs.  For additional information about Lexicon and its programs, please visit www.lexpharma.com.

Safe Harbor Statement

This press release contains "forward-looking statements," including statements relating to Lexicon's clinical development of LX4211, characterizations of the
'/>"/>

SOURCE Lexicon Pharmaceuticals, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Lexicon Receives Funding for Phase 2 Clinical Trial of LX4211 in Type 1 Diabetes
2. Lexicon Presents Data Regarding the Mechanism of Action and Safety of LX4211 at American Diabetes Association Meeting
3. Lexicon Announces Positive Results of LX4211 Phase 2b Trial For Type 2 Diabetes
4. Lexicon Announces Publication of Results of Two Studies of LX4211 in Patients with Type 2 Diabetes in the Journal Clinical Pharmacology & Therapeutics
5. LX4211 Phase 2b Results Presented At American Heart Association Annual Conference
6. Lexicon Advances LX4211 In Type 1 Diabetes Phase 2 Trial
7. Lexicon Presents Data at the American Diabetes Association Meeting On Blood Pressure Reduction and Weight Loss In Clinical Trial of LX4211
8. Greenville Hospital System Achieves Dramatic Improvement in Hand Hygiene Compliance Rates Using New Technology from DebMed®
9. Acuo Technologies Grows European Business and Achieves Successful Connectathon Results in Bern, Switzerland
10. CMC Biologics Achieves Successful Pre-Approval European GMP Inspection by MHRA for Commercial Manufacturing
11. QIAGEN Achieves Personalized Healthcare Milestone with U.S. Approval of Companion Diagnostic for Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... May 22, 2015 The leading companies ... billion global cardiac rhythm management device market dominate ... that Medtronic, St. Jude Medical, Boston Scientific and ... this market segment. The healthcare market research publisher,s ... uses 2015 as a base year, providing forecasts ...
(Date:5/22/2015)... ROCKVILLE, Md. , May 22, 2015 /PRNewswire/ ... "RegeneRx") today announced a peer-reviewed publication of the ... study evaluating RGN-259 (RegeneRx,s preservative-free eye drops) for ... Inc.,s controlled adverse environment (CAE ® ) model.  ... and the results, which were previously disseminated by ...
(Date:5/22/2015)... May 22, 2015 Research and Markets ... of the "Latest Regulations on Pharmaceutical International ... their offering. This is first time ... guidance on international multi-center clinical trials of drugs ... begun to be implemented on March 1, 2015. ...
Breaking Medicine Technology:Kalorama: Top Companies Dominate Cardiac Defibrillator Market 2Kalorama: Top Companies Dominate Cardiac Defibrillator Market 3Kalorama: Top Companies Dominate Cardiac Defibrillator Market 4Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 2Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 3Complete Data from RegeneRx Phase II Dry Eye Trial Published in Current Issue of Clinical Ophthalmology 42015 Regulations on Pharmaceutical International Multi-Center Clinical Trials in China 2
... 11, 2011 Instacare Corp. (OTCQB: ISCR), the exclusive ... targeted at the $20 billion diabetes care marketplace, a ... for the chronically ill, and a leading developer of ... technologies, today announced that its Board of Directors has ...
... N.J., May 11, 2011 Pharmaceutical giants seeking new ... information on the pharma industry all know there,s only ... most successful and time-tested event for pharma industry leaders- ... 2011 in Parsippany, New Jersey ( www.pharmaciconference.com ). ...
Cached Medicine Technology:Instacare Corp. Board of Directors Considers Recent Merger Proposal Inadequate 2Pharma Elite to Unveil Latest Industry News/Program Agenda with 70+ Expert Speakers at Exclusive Event: Pharma CI Conference, September 13-14, 2011 in New Jersey 2
(Date:5/23/2015)... 23, 2015 On May 16, the team ... event was a 5k mud obstacle run that raised funds ... million people worldwide, and the reason we participated was to ... Davis, owner of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the ... , The event was not only attended by eXtreme Bodyshaping ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 Add High-Quality prismatic ... Pixel Film Studios. , It's as simple as dragging and ... the included tool for full effect. , Including over ... high-dynamic range 5k sensors making this the ultimate bundle for ... flares included in this package are movie files designed for ...
(Date:5/22/2015)... San Francisco, CA (PRWEB) May 22, 2015 ... is hosting two exciting events in June. They will ... First Professional Doctorate and a two-day class on Classical ... 1:30-2:30 p.m. June 3, Dr. Steve Given, the Dean ... he will discuss the new First Professional Doctorate program. ...
(Date:5/22/2015)... 2015 Following yesterday’s announcement that Ascenta ... US-based health brand Nature’s Way, Marc St-Onge has affirmed ... Ascenta Skin is an integral part of the agreement ... opportunity to further develop Ascenta Skin into a leading ... is a breakthrough, anti-aging skincare supplement featuring 6 active ...
(Date:5/22/2015)... MA (PRWEB) May 22, 2015 ... Hart, MS/CCC, SLP, RAC-CT, CHHRP-QT, Vice President of ... “A very important ‘language’ that impacts how care ... the leader in long term care reimbursement, operations ... education programs and talent management, launches a new ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:ACTCM Announces Upcoming June Events 2Health News:Ascenta Skin President Announces Plans to Grow Brand 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 2Health News:Harmony Healthcare International Takes the Lead in Launching ICD-10 Coding Transition in Post-Acute Care 3
... ... ... nonprofit organization founded to accelerate research in Lou Gehrig,s disease, launched its “Art, Life, Spring” ... mission. The auction will be open for bidding online from May 3, 2010 through ...
... ... directors and scientists attended 2010 Council of Physicians and Scientists (C.O.P.S.) in Dallas to ... ... Scientists, an invitation-only event sponsored by IntegraMed (integramed.com), concluded their annual conference on Saturday, ...
... DNA is under constant siege from a variety of damaging ... repair that damage has broad health implications, from aging and ... DNA damage are quite limited, but MIT researchers have developed ... to make an impact on human health. The ...
... It appears that people are listening to doctors, orders to ... study of non-melanoma skin cancer, Andrei Metelitsa, Gordon Jung and ... are going down in men and have levelled off for ... that skin cancer rates are on the rise. Metelitsa and ...
... Johns Hopkins have identified a possible protein trigger responsible ... tiny clumps of inflammatory cells that each year leave ... and almost all major organs in hundreds of thousands ... a persistent mystery for nearly a century, strikes mostly ...
... genetic trait could lead researchers to better insect repellents, they ... are not turned off by the widely used insect repellent ... These "insensitive" mosquitoes have defects in their ability to smell ... from generation to generation, the researchers reported in the May ...
Cached Medicine News:Health News:Prize4Life Launches “Art, Life, Spring” Online Art Auction to Raise Funds for Lou Gehrig's Disease Research 2Health News:Prize4Life Launches “Art, Life, Spring” Online Art Auction to Raise Funds for Lou Gehrig's Disease Research 3Health News:IntegraMed Conference Identifies 3 Trends That Will Transform Fertility Success Rates 2Health News:IntegraMed Conference Identifies 3 Trends That Will Transform Fertility Success Rates 3Health News:Rapid analysis of DNA damage now possible 2Health News:A century-old puzzle comes together: Scientists ID potential protein trigger in lung disease sarcoidosis 2Health News:A century-old puzzle comes together: Scientists ID potential protein trigger in lung disease sarcoidosis 3Health News:Not All Mosquitoes Deterred by DEET 2Health News:Not All Mosquitoes Deterred by DEET 3
Army navy retractor set....
Jaffe wire lid retractor, large pair....
Sharp. 4 mm wide. Hand-Held...
Flexible rake retractor, 3 blunt prongs....
Medicine Products: